CDKN2A and acute lymphoblastic leukemia: Over-expression of wild-type p16INK4A(p.148A) significantly inhibited leukaemic transformation by BCR–ABL1 (Fig. 2a, Supplementary Fig. 2), consistent with its role as a critical tumour suppressor in ALL.